SPY397.05+7.42 1.90%
DIA318.89+6.47 2.07%
IXIC11,535.28+180.66 1.59%

BRIEF-Bellus Health To Present Late-Breaking Clinical Data From The Phase 2B Soothe Trial Of Blu-5937

reuters.com · 05/02/2022 07:22
BRIEF-Bellus Health To Present Late-Breaking Clinical Data From The Phase 2B Soothe Trial Of Blu-5937

- BELLUS Health Inc BLU:

  • BELLUS HEALTH TO PRESENT LATE-BREAKING CLINICAL DATA FROM THE PHASE 2B SOOTHE TRIAL OF BLU-5937 AT THE ATS 2022 INTERNATIONAL CONFERENCE

Source text for Eikon: ID:nBw2nwBXFa

Further company coverage: BLU


((reuters.briefs@thomsonreuters.com;))